EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
H.C. Wainwright Keeps Buy Rating on Oruka (ORKA) After Apogee Acquisition News
AbbVie Inc. (ABBV) Hits New Milestone with Venetoclax on Chronic Lymphocytic Leukemia (CLL) Treatment
AbbVie (ABBV) Faces Congressional Scrutiny Over China Clinical Trials
Regenxbio Shares Rise on $100 Million Milestone Payment After First Patient Dosed in Eye-Disease Trial | Morningstar
Erste Group Bank Has Negative View of AbbVie FY2027 Earnings
AbbVie Inc. $ABBV Shares Acquired by IFM Investors Pty Ltd
27,397 Shares in AbbVie Inc. $ABBV Acquired by Capricorn Fund Managers Ltd
Galderma Application for Product to Rival Botox Turned Down Again by FDA | Morningstar
Feasibility and safety of rapid glofitamab ramp-up
Wall Street Says to Buy These 3 Dividend Aristocrats
AbbVie (NYSE:ABBV) Shares Down 1.1% - Here's Why - Zolmax
Stocks bid on quarter end while bonds fall as focus shifts to data - Newsquawk US Market Wrap
5 Best Dividend Aristocrat Stocks To Buy Now
Merck, AbbVie probed by US lawmakers over China clinical trials: report
Promising Pharmaceutical Stocks To Research - June 30th - Stock Observer
Nxera Pharma Secures $10 Million Milestone Payment From AbbVie In Neurological Disease Collaboration
Forum Financial Management LP Reduces Stock Position in AbbVie Inc. $ABBV - Markets Daily
US Lawmakers Investigate Merck and AbbVie for Ties to China's Military Drug Trials, ETPharma
Erste Group Bank Has Negative View of AbbVie FY2026 Earnings
3 Stocks Estimated To Be Trading At A Discount Of Up To 48.9%
US House committee opens investigation into Merck, AbbVie China drug trials
Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases
)
Fresh millions swell Nxera haul from AbbVie alliance with a further $1.2bn in play
Is AbbVie (ABBV) One of the 10 Best July Dividend Stocks to Buy?
AbbVie (ABBV) Stock After 1-Year 41% Rally And Apogee Deal Valuation Check
2 S&P 500 Stocks with Promising Prospects and 1 We Find Risky
Union Bancaire Privee UBP SA Sells 67,022 Shares of AbbVie Inc. $ABBV
Promising Pharmaceutical Stocks To Watch Today - June 29th - Daily Political
Patton Fund Management Inc. Cuts Holdings in AbbVie Inc. $ABBV
Janney Montgomery Scott LLC Has $262.57 Million Stock Holdings in AbbVie Inc. $ABBV - Stock Observer
Pharm giant AbbVie acquires new company for $10B
AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
AbbVie Receives Positive CHMP Opinion for Upadacitinib for the Treatment of Adults and Adolescents with Severe Alopecia Areata | INN
AbbVie Inc. $ABBV Shares Sold by Orange Investment Advisors Inc. - Daily Political
Going Back to the Well in a Sector That's Working
RBC Capital Maintains a Sector Perform Rating on Regeneron (REGN) - Here's Why
AbbVie Inc. $ABBV Stock Holdings Boosted by Venturi Wealth Management LLC
Sterling Capital Management LLC Sells 3,843 Shares of AbbVie Inc. $ABBV - Stock Observer
AbbVie (ABBV) Is Up 17.0% After EU MAVIRET Expansion And New Global Label Wins - What's Changed - Simply Wall St News
AbbVie (ABBV) Wins Health Canada Approval for Boey
AbbVie (ABBV) to Acquire Apogee Therapeutics
Medical Stocks To Follow Now - June 27th - Zolmax
Pharmaceutical Stocks To Research - June 27th - Daily Political
90,100 Shares in AbbVie Inc. $ABBV Bought by Louisiana State Employees Retirement System
AbbVie Inc. $ABBV Shares Sold by Aaron Wealth Advisors LLC
AbbVie (NYSE:ABBV) Upgraded by Wall Street Zen to Strong-Buy Rating
Barton Investment Management Has $1.65 Million Holdings in AbbVie Inc. $ABBV - Daily Political
SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric
AbbVie (NYSE:ABBV) Stock Price Up 3.4% - Here's What Happened
AbbVie's Skyrizi Gets FDA Approval For Pediatric Use | Morningstar
AbbVie says FDA approves Skyrizi for pediatric use in psoriatic disease
Healthcare stocks have become a haven for investors ditching tech | Morningstar
AbbVie (ABBV) Wins EU Approval For Pediatric Skyrizi And Broader Maviret Use
AbbVie On Pace For Record Closing High - Data Talk | Morningstar
Fidelity (FHLC) vs. iShares (IXJ): Which Healthcare ETF Delivers Better Value?
BTC Capital Management Inc. Increases Position in AbbVie Inc. $ABBV - Zolmax
AbbVie (NYSE:ABBV) Hits New 52-Week High - Here's What Happened - Daily Political
Blue Trust Inc. Reduces Stock Holdings in AbbVie Inc. $ABBV
Apella Capital LLC Raises Holdings in AbbVie Inc. $ABBV
Cardano Risk Management B.V. Sells 4,908,260 Shares of AbbVie Inc. $ABBV - Stock Observer
AbbVie Inc. (NYSE:ABBV) Receives Consensus Rating of "Moderate Buy" from Brokerages - Daily Political
Will AbbVie's (ABBV) Pediatric Expansions Reveal a Deeper Shift in Its Growth Mix?
AbbVie (NYSE:ABBV) Shares Up 3.7% - Should You Buy?
Miller Howard Investments Inc. NY Sells 3,294 Shares of AbbVie Inc. $ABBV
OP Asset Management Ltd Purchases Shares of 310,902 AbbVie Inc. $ABBV
AbbVie Stock Leads 3 Cash Flow Picks Trading Below Estimated Value
3 Psychedelic Stocks In The Space AbbVie Bet A Billion Dollars On
AbbVie Stock And 2 Cash Flow Picks Worth A Closer Look
Canaccord Says AbbVie's (ABBV) Apogee Deal Strengthens Long-Term Growth Outlook
Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial
AbbVie (NYSE:ABBV) Trading 6.3% Higher - Still a Buy? - Zolmax
Why I Can't Stop Buying This Unstoppable Dividend Juggernaut
AbbVie's $11 Billion Immunology Bet
FDA Complete Response Letter (CRL) Explained: What It Means For Biotech Stocks
64 Years Old With $1.1 Million in a Traditional IRA. Here's Where I'm Allocating Capital
BOTOX® Cosmetic (onabotulinumtoxinA) Introduces The Confidence Collective's Entrepreneur Class of 2026 | Morningstar
After Apogee, 3 More Biotech Buyout Targets Wall Street Can't Stop Watching - 24/7 Wall St.
AbbVie Inc. $ABBV Shares Acquired by Signal Advisors Wealth LLC
SVB Wealth LLC Sells 10,374 Shares of AbbVie Inc. $ABBV
Great Place To Work Reveals Southeast Asia's Best Workplaces™ in Healthcare & Biopharma
SVB Wealth LLC Reduces Position in AbbVie Inc. $ABBV - Daily Political
Long-term follow-up of the transplant-eligible cohort of the EMN12/HOVON-129 study for primary plasma cell leukemia patients
Apogee Therapeutics downgraded to Hold from Buy at TD Cowen
AbbVie Just Sparked a 46% Rally in Apogee. Here's Why This $10.9 Billion Deal Could Be a Win for AbbVie Investors.
Therapeutics Stocks Q1 Recap: Benchmarking Biogen (NASDAQ:BIIB)
AbbVie (NYSE:ABBV) Receives "Overweight" Rating from Piper Sandler - Markets Daily
AbbVie (NYSE:ABBV) Receives "Overweight" Rating from Piper Sandler - Zolmax
AbbVie (ABBV) Is Buying Apogee Therapeutics For $10.9 Billion To Rebuild Its Pipeline
AbbVie (ABBV) Gains EU Approval for Expanded Use of Hepatitis C Treatment Maviret
3 Biotech Takeover Targets Wall Street Is Watching After the Apogee Deal
AbbVie (ABBV) Secures EU Approval for Skyrizi in Pediatric Psoriasis Treatment
Apogee Therapeutics (NASDAQ:APGE) Stock Rating Lowered by Citigroup - Zolmax
Apogee Therapeutics (NASDAQ:APGE) Stock Rating Lowered by Citigroup - Markets Daily
AbbVie News
USD/CHF Price Forecast: Evaluating the 2026 Breakout Amid Fed and SNB Policy Divergence
SK Hynix Equity Analysis 2026: The Intersection of AI Memory Dominance and Valuation Arbitrage
Dow Advances on Value Rotation While Tech Sell-Off and Plunging Crude Drag S&P 500, Nasdaq Lower
Latest news
Show more
Spot Gold Rebounds Above $4,000 as US Manufacturing Slows and Fed Shifts Messaging
Crude Oil Prices Extend Post-War Slump as Supply Risks Fade and Hormuz Traffic Rebounds
Bitcoin Price Outlook: Could BTC Fall Toward $53,000 After Losing $60,000 Support?
Brent Holds Above $73 as Iran Talks Uncertainty Offsets Hormuz Recovery
Gold Price Today, July 1: Spot Gold Faces Worst Quarterly Loss in 13 Years
